Institutions / Armistice Capital, LLC
Armistice Capital, LLC
CIK 1601086 · Institution · as of Dec 31, 2025
Portfolio value
$4.08B
Positions
357
As of
Dec 31, 2025
Top holdings
Dec 31, 2025View all 357 →
| Company | Value | % of portfolio |
|---|---|---|
| PTC Therapeutics Inc | $212.83M | 5.2% |
| Madrigal Pharmaceuticals, Inc. | $154.73M | 3.8% |
| Immunovant, Inc.IMVT | $146.09M | 3.6% |
| Travere Therapeutics, Inc. | $143.82M | 3.5% |
| Supernus Pharmaceuticals Inc | $137.37M | 3.4% |
| Neurocrine Biosciences Inc | $116.33M | 2.8% |
| Incyte Corp | $108.46M | 2.7% |
| Amazon.com Inc | $84.86M | 2.1% |
| DENTSPLY SIRONA Inc. | $83.42M | 2.0% |
| Agios Pharmaceuticals, Inc. | $82.64M | 2.0% |
| Freshpet, Inc. | $78.97M | 1.9% |
| Kenvue Inc. | $68.87M | 1.7% |
| GE HealthCare Technologies Inc. | $64.96M | 1.6% |
| Regeneron Pharmaceuticals, Inc. | $64.84M | 1.6% |
| Dyne Therapeutics, Inc. | $63.56M | 1.6% |
| Cytokinetics Inc | $63.08M | 1.5% |
| Alphabet Inc. | $61.48M | 1.5% |
| Microsoft Corp | $57.23M | 1.4% |
| Ironwood Pharmaceuticals Inc | $54.00M | 1.3% |
| Kura Oncology, Inc. | $51.29M | 1.3% |
| elf Beauty Inc | $50.03M | 1.2% |
| Gsk PLC | $49.04M | 1.2% |
| Argenx SE | $48.78M | 1.2% |
| Alibaba Group Holding LtdBABA | $46.77M | 1.1% |
| Starbucks Corp | $46.30M | 1.1% |
Activity
Dec 31, 2025
InsidersInstitutions
This fund's 13F position changes — what it's buying and selling.No quarter-over-quarter changes yet — position changes appear once we've ingested two consecutive 13F filings for this manager. We currently hold 1 quarter of holdings.